Nonneoplastic mucocutaneous lesions in organ transplant recipients

Transplant International

Volumn 24, Issue 11, 2011, Pages 1041-1050

  Ponticelli, Claudio ^a   Bencini, Pier Luca ^b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b Istituto di Chirurgia e Laser Terapia in Dermatologia (ICLID)   (Italy)

Author keywords

fungal infections; mucocutaneous lesions; transplant complications; transplantation and skin lesions

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; DOXYCYCLINE; EVEROLIMUS; GLUCOCORTICOID; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID; RAPAMYCIN; SPIRONOLACTONE; TACROLIMUS;

ACNE; ALOPECIA; APHTHOUS STOMATITIS; APHTHOUS ULCER; ATOPIC DERMATITIS; CANDIDIASIS; CONDYLOMA; CUSHINGOID SYNDROME; DISEASE PREDISPOSITION; DOSE RESPONSE; FOLLICULITIS; GINGIVA HYPERPLASIA; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HAIR DISEASE; HAIR GROWTH; HUMAN; HYPERPIGMENTATION; HYPERTRICHOSIS; IMMUNOSUPPRESSIVE TREATMENT; LEISHMANIASIS; NAIL DISEASE; NECROTIZING FASCIITIS; ONYCHOLYSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PURPURA; REVIEW; SIDE EFFECT; SKIN ATROPHY; SKIN CANCER; SKIN DEFECT; SKIN INFECTION; TINEA VERSICOLOR; VERRUCA VULGARIS; WART VIRUS;

DERMATOMYCOSES; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; SKIN DISEASES; SKIN DISEASES, BACTERIAL; SKIN DISEASES, INFECTIOUS; SKIN DISEASES, PARASITIC; TRANSPLANTS;

EID: 80053937477     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2011.01308.x     Document Type: Review

References (111)

1. Wisgerhof HC, Edelbroek JR, de Fijter JW, Feltkamp MC, Willemze R, Bouwes Bavinck JN,. Trends of skin diseases in organ-transplant recipients transplanted between 1966 and 2006: a cohort study with follow-up between 1994 and 2006. Br J Dermatol 2010; 162: 390.
2. Formicone F, Fargnoli MC, Pisani F, Rascente M, Famulari A, Peris K,. Cutaneous manifestations in Italian kidney transplant recipients. Transplant Proc 2005; 37: 2527.
3. Lugo-Janer G, Sánchez JL, Santiago-Delpin E,. Prevalence and clinical spectrum of skin diseases in kidney transplant recipients. J Am Acad Dermatol 1991; 24: 410.
4. Alper S, Kilinc I, Duman S, et al. Skin diseases in Turkish renal transplant recipients. Int J Dermatol 2005; 44: 939.
5. Zamanian A, Mahjub H, Mehralian A,. Skin diseases in kidney transplant recipients. Urol J 2006; 3: 230.
6. Cooper SM, Woinarowska F,. Photo-damage in North-European renal transplant recipients is associated with use of calcium channel blockers. Clin Exp Dermatol 2003; 28: 588.
7. Kaur G, Verhamme KM, Dieleman JP, et al. Association between calcium channel blockers and gingival hyperplasia. J Clin Periodontol 2010; 37: 625.
8. Butler JA, Roderick P, Mullee M, Mason JC, Peveler RC,. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation 2004; 77: 769.
9. Rathnayake D, Sinclair R,. Use of spironolactone in dermatology. Skinmed 2010; 8: 328.
10. Lumsden KR, Nelson AM, Dispenza MC, et al. Isotretinoin increases skin surface levels of neutrophil gelatinase-associated lipocalin in patients treated for severe acne. Br J Dermatol 2011; 10: 1365.
11. Stotland M, Chapas AM, Brightman L, et al. The safety and efficacy of fractional photothermolysis for the correction of striae distensae. J Drugs Dermatol 2008; 7: 857.
12. Euvrard S, Kanitakis J, Cochat P, Cambazard F, Claudy A,. Skin disease in children with organ transplant. J Am Acad Dermatol 2001; 44: 932.
13. Webb NJ, Coulthard MG, Trompeter RS, et al. Correlation between finger-prick and venous ciclosporin levels: association with gingival overgrowth and hypertrichosis. Pediatr Nephrol 2007; 22: 2111.
14. Vexiau P, Fiet J, Boudou Ph, et al. Increase in plasma 5 alpha -androstase-3 alpha, 17 alpha-diol glucuronide as a marker of peripheral androgen action in hirsutism: a side-effect induced by cyclosporine A. J Steroid Biochem 1990; 35: 133.
15. Rittmaster RS,. Medical treatment of androgen-dependent hirsutism. J Clin Endocrinol Metab 1995; 80: 2559.
16. Walker RG, Cottrell S, Sharp K, et al. Conversion of cyclosporine to tacrolimus in stable renal allograft recipients: quantification of effects on the severity of gingival enlargement and hirsutism and patient-reported outcomes. Nephrology (Carlton). 2007; 12: 607.
17. Leyral C, Beylot-Barry M, Vergier B, et al. Cyclosporine-induced follicular eruption. Ann Dermatol Venereol 2008; 135: 58.
18. Ponticelli C, Zorzi F,. The skin in renal transplant recipients. In:, Massry SG, Glassock RJ, eds. Textbook of Nephrology. Philadelphia: Lippincott Williams and Wilkins, 2001: 1685-1688.
19. Spoildorio LC, Spoildorio DM, Neves KA, Gonzaga HF, Almeida OP,. Morphological evaluation of combined effects of cyclosporine and nifedipine on gingival overgrowth in rats. J Periodontal Res 2002; 37: 192.
20. Baratynska M, Radwan-Oczko M, Falkiewicz K, Klinger M, Szyber P,. Gingival overgrowth in kidney transplant recipients treated with cyclosporine and its relationship with chronic graft nephropathy. Transplant Proc 2003; 35: 2238.
21. Nash MM, Zaltzman JS,. Efficacy of azithromicin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients. Transplantation 1998; 65: 1611.
22. Tokgoz B, Sari HI, Yildiz O,. Effects of azithromycin on cyclosporine-induced gingival hyperplasia in renal transplant patients. Transplant Proc 2004; 36: 2699.
23. Gonçalves SC, Díaz-Serrano KV, de Queiroz AM, Palioto DB, Faria G,. Gingival overgrowth in a renal transplant recipient using cyclosporine A. J Dent Child (Chic) 2008; 75: 313.
24. Talbot D, Rix D, Abusin K, et al. Alopecia as a consequence of tacrolimus therapy in renal transplantation. Transplantation 1997; 64: 1631.
25. Tricot L, Lebbe C, Pillebout E, et al. Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients. Transplantation 2005; 80: 1546.
26. Ponte GM, Baidal DA, Romanelli P, et al. Resolution of severe atopic dermatitis after tacrolimus withdrawal. Cell Transplant 2007; 16: 23.
27. Ponticelli C,. Can mTOR inhibitors reduce the risk of late kidney allograft failure? Transpl Int 2008; 21: 2.
28. Campistol JM, de Fijter JW, Flechner SM, Langone A, Morelon E, Stockfleth E,. mTOR inhibitor-associated dermatologic and mucosal problems. Clin Transplant 2010; 24: 149.
29. Van Gelder T, ter Meulen CG, Hené R, Weimar W, Hoistma A,. Oral ulcers in kidney transplant recipients treated with sirolimus and mycophenolate mofetil. Transplantation 2003; 75: 788.
30. Kunzle N, Venetz JP, Pascual M, Panizzon RG, Laffitte E,. Sirolimus-induced acneiform eruption. Dermatology 2005; 211: 366.
31. Tracey C, Hawley C, Griffin AD, Strutton G, Lynch S,. Generalized, pruritic, ulcerating maculopapular rash necessitating cessation of sirolimus in a liver transplantation patient. Liver Transpl 2005; 11: 987.
32. Mahé E, Morelon E, Lechaton S, Kreis H, De Prost Y, Bodemer C,. Sirolimus-induced onychopathy in renal transplant recipients. Ann Dermatol Venereol 2006; 133: 531.
33. Lawson DH, Lovatt GE, Gurton CS, Hennings RC,. Adverse effects of azathioprine. Adverse Drug React Acute Poisoning Rev 1984; 3: 161.
34. Vermeulen T, Rodrigus IE, Vrints CJ, Conraads V,. Severe stomatitis complicating immune-suppressive switch after cardiac transplantation. Acta Chir Belg 2010; 110: 339.
35. Rault R,. Mycophenolate-associated onycholysis. Ann Intern Med 2000; 133: 92.
36. Hogewoning AA, Goettsch W, van Loveren H, de Fijter JW, Vermeer BJ, Bouwes Bavinck JN,. Skin infections in renal transplant recipients. Clin Transplant 2001; 15: 3.
37. Chen QP, Aw DC,. Epidemiology of skin diseases in renal transplant recipients in a tertiary hospital. Ann Acad Med Singapore 2010; 39: 904.
38. Lally A, Casabonne D, Imko-Walczuk B, Newton R, Wojnarowska F,. Prevalence of benign cutaneous disease among Oxford renal transplant recipients. J Eur Acad Dermatol Venereol 2011; 25: 462.
39. Johnson RA, Wang X, Ma XL, Huong SM, Huang ES,. Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J Virol 2001; 75: 6022.
40. Kudchodkar SB, Yu Y, Maguire TG, Alwine JC,. Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexes. Proc Natl Acad Sci U S A 2006; 103: 14182.
41. Viganò M, Dengler T, Mattei MF, et al. Study Investigators Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil in de novo cardiac transplant recipients: a randomized, multicenter study. Transpl Infect Dis 2010; 12: 23.
42. Ponticelli C,. Herpes viruses and tumours in kidney transplant recipients. The role of immunosuppression. Nephrol Dial Transplant 2011; 26: 1769.
43. Virgili A, Zampino MR, Mantovani L,. Fungal skin infections in organ transplant recipients. Am J Clin Dermatol 2002; 3: 19.
44. Ribeiro PM, Bacal F, Koga-Ito CY, Junqueira JC, Jorge AO,. Presence of Candida spp. in the oral cavity of heart transplantation patients. J Appl Oral Sci 2011; 19: 6.
45. Golecka M, Oldakowska-Jedynak E, Mierzwinska-Nastalska E, Adamczyk-Sosinska E,. Candida-associated denture stomatitis in patients after immunosuppression therapy. Transplant Proc 2006; 38: 155.
46. Miele PS, Levy CS, Smith MA, et al. Primary cutaneous fungal infections in solid organ transplantation: a case series. Am J Transplant 2002; 2: 678.
47. Gulec AT, Demirbilek M, Seckin D, et al. Superficial fungal infections in 102 renal transplant recipients: a case-control study. J Am Acad Dermatol 2003; 49: 187.
48. Lally A, Casabonne D, Newton R, Wojnarowska F,. Seborrheic dermatitis among Oxford renal transplant recipients. J Eur Acad Dermatol Venereol 2010; 24: 561.
49. Tessari G, Naldi L, Piaserico S, et al. Incidence and clinical predictors of primary opportunistic deep cutaneous mycoses in solid organ transplant recipients: a multicenter cohort study. Clin Transplant 2010; 24: 328.
50. Gupta A, Khaira A, Lata S, Sharma A, Tiwari SC,. Primary cutaneous aspergillosis in renal transplant recipient. Saudi J Kidney Dis Transpl 2009; 20: 848.
51. Ramos A, Ussetti P, Laporta R, Lázaro MT, Sánchez-Romero I,. Cutaneous aspergillosis in a lung transplant recipient. Transpl Infect Dis 2009; 11: 471.
52. Abuav R, McGirt LY, Kazin RA,. Cryptococcal panniculitis in an immunocompromised patient: a case report and review of the literature. Cutis 2010; 85: 303.
53. Sun HY, Alexander BD, Lortholary O, et al. Cutaneous cryptococcosis in solid organ transplant recipients. Med Mycol 2010; 48: 785.
54. Shuttleworth D, Philpot CM, Salaman JR,. Cutaneous fungal infection following renal transplantation: a case control study. Br J Dermatol 1987; 117: 585.
55. Marques SA, Hozumi S, Camargo RM, Carvalho MF, Marques ME,. Histoplasmosis presenting as cellulitis 18 years after renal transplantation. Med Mycol 2008; 46: 725.
56. Bourlond A, Alexandre G,. Dermal alternariasis in a kidney transplant recipient. Dermatologica 1984; 168: 152.
57. Boyce RD, Deziel PJ, Otley CC, et al. Phaeohyphomycosis due to Alternaria species in transplant recipients. Transpl Infect Dis 2010; 12: 242.
58. Peña-Penabad C, Durán MT, Yebra MT, Rodríguez-Lozano J, Vieira V, Fonseca E,. Chromomycosis due to Exophiala jeanselmei in a renal transplant recipient. Eur J Dermatol 2003; 13: 305.
59. Franco A, Aranda I, Navas F, Olivares J,. Follow-up on a transplant recipient with chromomycosis. Nephrol Dial Transplant 1997; 12: 852.
60. Dupont C, Duong TA, Mallet S, et al. Unusual presentation of chromoblastomycosis due to Cladophialophora carrionii in a renal and pancreas transplant recipient patient successfully treated with posaconazole and surgical excision. Transpl Infect Dis 2010; 12: 180.
61. Page AV, Evans AJ, Snell L, Liles WC,. Primary cutaneous mucormycosis in a lung transplant recipient: case report and concise review of the literature. Transpl Infect Dis 2008; 10: 419.
62. Ashkenazi-Hoffnung L, Bilavsky E, Avitzur Y, Amir J,. Successful treatment of cutaneous zygomycosis with intravenous amphotericin B followed by oral posaconazole in a multivisceral transplant recipient. Transplantation 2010; 90: 1133.
63. Ounissi M, Abderrahim E, Trabelsi S, et al. Hyalohyphomycosis caused by Paecilomyces lilacinus after kidney transplantation. Transplant Proc 2009; 41: 2917.
64. Van Schooneveld T, Freifeld A, Lesiak B, Kalil A, Sutton DA, Iwen PC,. Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature. Transpl Infect Dis 2008; 10: 117.
65. Garzoni C, Garbino J,. New azoles as first line therapy for Paecilomyces lilacinus in transplant patients. Transpl Infect Dis 2008; 10: 149.
66. Gullberg RM, Quintanilla A, Levin ML, Williams J, Phair JP,. Sporotrichosis: recurrent cutaneous, articular, and central nervous system infection in a renal transplant recipient. Rev Infect Dis 1987; 9: 369.
67. Bakr NI, El-Sawy E, Hamdy AF, Bakr MA,. Skin infections in Egyptian renal transplant recipients. Transpl Infect Dis 2011; 13: 131.
68. Ghannoum MA, Welshenbaugh A, Imamura Y, Isham N, Mallefet P, Yamaguchi H,. Comparison of the in vitro activity of terbinafine and lanoconazole against dermatophytes. Mycoses 2010; 53: 311.
69. Chambers WM, Millar A, Jain S, Burroughs AK,. Terbinafine-induced hepatic dysfunction. Eur J Gastroenterol Hepatol 2001; 13: 1115.
70. Balfour Jr HH,. Antiviral drugs. N Engl J Med 1999; 340: 1255.
71. Brink AA, van Gelder M, Wolffs PF, Bruggeman CA, van Loo IH,. Compartmentalization of acyclovir-resistant varicella zoster virus: implications for sampling in molecular diagnostics. Clin Infect Dis 2011; 52: 982.
72. Furth SL, Fivush BA,. Varicella vaccination in pediatric kidney transplant candidates. Pediatr Transplant 2002; 6: 97.
73. Shiley K, Blumberg E,. Herpes viruses in transplant recipients: HSV, VZV, human herpes viruses, and EBV. Hematol Oncol Clin North Am 2011; 25: 171.
74. Jeyaratnam D, Robson AM, Hextall JM, Wong W, MacMahon E,. Concurrent verrucous and varicelliform rashes following renal transplantation. Am J Transplant 2005; 5: 1777.
75. Ponticelli C, Passerini P,. Gastrointestinal complications in renal transplant recipients. Transpl Int 2005; 18: 643.
76. Leigh IM, Glover MT,. Cutaneous warts and tumours in immunosuppressed patients. J R Soc Med 1995; 88: 61.
77. Barba A, Tessari G, Talamini G, Chieregato GC,. Analysis of risk factors for cutaneous warts in renal transplant recipients. Nephron 1997; 77: 422.
78. Krüger-Corcoran D, Stockfleth E, Jürgensen JS, et al. Human papillomavirus-associated warts in organ transplant recipients. Incidence, risk factors, management. Hautarzt 2010; 61: 220.
79. Reuschenbach M, Tran T, Faulstich F, et al. High-risk human papillomavirus in non-melanoma skin lesions from renal allograft recipients and immunocompetent patients. Br J Cancer 2011; 104: 1334.
80. Köhler A, Gottschling M, Manning K, et al. Genomic characterization of ten novel cutaneous human papillomaviruses from keratotic lesions of immunosuppressed patients. J Gen Virol 2011; 92: 1585.
81. Bouwes Bavinck JN, Neale RE, Abeni D, et al. Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. Cancer Res 2010; 70: 9777.
82. Patel HS, Silver AR, Levine T, Williams G, Northover JM,. Human papillomavirus infection and anal dysplasia in renal transplant recipients. Br J Surg 2010; 97: 1716.
83. Ganguly N, Waller S, Stasik CJ, Skikne BS, Ganguly S,. Giant anal condylomatosis after allogeneic bone marrow transplantation: a rare complication of human papilloma virus infection. Transpl Infect Dis 2008; 10: 56.
84. Feldmeyer L, Kamarashev J, Boehler A, et al. Molluscum contagiosum folliculitis mimicking tinea barbae in a lung transplant recipient. J Am Acad Dermatol 2010; 63: 169.
85. Stark S, Petridis AK, Ghim SJ, et al. Prevalence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancer. J Invest Dermatol 1998; 111: 696.
86. Gayed SL,. Topical imiquimod cream 5% for resistant perianal warts in a renal transplant patient. Int J STD AIDS 2002; 13: 501.
87. Cha S, Johnston L, Natkunam Y, Brown J,. Treatment of verruca vulgaris with topical cidofovir in an immunocompromised patient: a case report and review of the literature. Transpl Infect Dis 2005; 7: 158.
88. Kralund HH, Broesby-Olsen S, Bistrup C, Lorentzen HF,. Substantial effect of topical cidofovir 1% on recalcitrant warts in a renal-transplanted adolescent: a case report. Transplantation 2011; 91: e52.
89. Dharancy S, Catteau B, Mortier L, et al. Conversion to sirolimus: a useful strategy for recalcitrant cutaneous viral warts in liver transplant recipient. Liver Transpl 2006; 12: 1883.
90. Kostaki M, Venetz JP, Nseir G, et al. Giant warts in a kidney transplant patient: regression with sirolimus. Br J Dermatol 2010; 162: 1148.
91. Seal DV,. Necrotizing fasciitis. Curr Opin Infect Dis 2001; 14: 127.
92. Audard V, Pardon A, Claude O, et al. Necrotizing fasciitis during de novo minimal change nephritic syndrome in a kidney transplant recipient. Transpl Infect Dis 2005; 7: 89.
93. Maccario M, Tortorano AM, Ponticelli C,. Subcutaneous nodules and pneumonia in a kidney transplant recipient. Nephrol Dial Transplant 1998; 31: 681.
94. Caroti L, Zanazzi M, Rogasi P, et al. Subcutaneous nodules and infectious complications in renal allograft recipients. Transplant Proc 2010; 42: 1146.
95. Quirõs J, Herrero-Beaumont G, Tornero J, Castañeda S,. Subcutaneous nodules: initial manifestation of disseminated hematogenous tuberculosis. Med Clin (Barc) 1988; 91: 237.
96. Sattinger E, Meyer S, Costard-Jackle A,. Cutaneous tuberculosis mimicking erysipelas of the lower leg in a heart transplant recipient. Transplant Int 2011; 24: e51.
97. Pandian TK, Deziel PJ, Otley CC, Eid AJ, Razonable RR,. Mycobacterium marinum infections in transplant recipients: case report and review of the literature. Transpl Infect Dis 2008; 10: 358.
98. Garrison AP, Morris MI, Doblecki Lewis S, et al. Mycobacterium abscessus infection in solid organ transplant recipients: report of three cases and review of the literature. Transpl Infect Dis 2009; 11: 541.
99. Morales P, Gil A, Santos M,. Mycobacterium abscessus infection in transplant recipients. Transplant Proc 2010; 42: 3058.
100. Cakmak SK, Gönül M, Gül U, Unal T, Daǧlar E,. Norwegian scabies in a renal transplant patient. Australas J Dermatol 2008; 49: 248.
101. Abdo A, Kouri V, Burgos D, et al. Norwegian scabies associated with herpes simplex infection in a renal transplant patient. Transplantation 2009; 87: 943.
102. Sampathkumar K, Mahaldar AR, Ramakrishnan M, Prabahar S,. Norwegian scabies in a renal transplant patient. Indian J Nephrol 2010; 20: 89.
103. Mansy H, Somorin A, el-Sherif M, Eze C, al-Dusari S, Filobbos P,. Norwegian scabies complicated by fatal brain abscess in a renal transplant patient. Nephron 1996; 72: 32.
104. Antinori S, Cascio A, Parravicini C, Bianchi R, Corbellino M,. Leishmaniasis among organ transplant recipients. Lancet Infect Dis 2008; 8: 191.
105. Mirzabeigi M, Farooq U, Baraniak S, Dowdy L, Ciancio G, Vincek V,. Reactivation of dormant cutaneous Leishmania infection in a kidney transplant patient. J Cutan Pathol 2006; 33: 701.
106. Oliveira LF, Schubach AO, Martins MM, et al. Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. Acta Trop 2011; 118: 87.
107. Franke ED, Wignall FS, Cruz ME, et al. Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis. Ann Intern Med 1990; 113: 934.
108. Olliaro PL, Guerin PJ, Gerstl S, Haaskjold AA, Rottingen JA, Sundar S,. Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. Lancet Infect Dis 2005; 5: 763.
109. Wortmann G, Zapor M, Ressner R, et al. Liposomal amphotericin B for treatment of cutaneous leishmaniasis. Am J Trop Med Hyg 2010; 83: 1028.
110. Pimentel MI, Baptista C, Rubin EF, et al. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report. Rev Soc Bras Med Trop 2011; 44: 254.
111. Paloque L, Bouhlel A, Curti C, et al. Synthesis and evaluation of monoamidoxime derivatives: toward new antileishmanial compounds. Eur J Med Chem 2011; 46: 2984.